Hao Guo

Hao Guo

Harvard University - Cambridge / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 1391376
person_outline Hao Guo's MOST POPULAR ARTICLES
1-) Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast CancerSM Tolaney, WT Barry, CT Dang, DA Yardley, B Moy, PK Marcom, ...New England Journal of Medicine 372 (2), 134-141, 20156812015
2-) Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerS Shu, CY Lin, HH He, RM Witwicki, DP Tabassum, JM Roberts, ...Nature 529 (7586), 413-417, 20164922016
3-) Seven-year follow-up analysis of adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2–positive breast cancerSM Tolaney, H Guo, S Pernas, WT Barry, DA Dillon, L Ritterhouse, ...Journal of Clinical Oncology 37 (22), 1868, 20192092019
4-) Association of cell-free DNA tumor fraction and somatic copy number alterations with survival in metastatic triple-negative breast cancerDG Stover, HA Parsons, G Ha, SS Freeman, WT Barry, H Guo, ...Journal of Clinical Oncology 36 (6), 543, 20182372018
5-) Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancerDG Stover, CR Gil Del Alcazar, J Brock, H Guo, B Overmoyer, J Balko, ...NPJ Breast cancer 4 (1), 1-9, 20181252018